LONDON, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Bionical Emas (“Bionical”) or (“the Company”), the Early Access Programs and Clinical Trial Supply business, is selling its Clinical Development division, ...

Willington, UK, June 19, 2024 – Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare companies and the NHS, ...

LONDON, UK – 29 May 2025: Bionical Emas, a global provider of Clinical Trial Services, announces an exclusive global clinical trial supply agreement with Pharma Resources GmbH, German pharmaceutical ...

Emas Pharma, a CRO that provides biopharma and medical device services, has been bought by outsourced specialist Bionical and joined the latter’s existing clinical services business. Founded in 1998 ...

HILLSBOROUGH, NJ / ACCESSWIRE / May 28, 2017 / Bionical, a partner to the pharmaceutical and biotech industries, is pleased to announce that Andy Woolf, CEO, US has been named to PM360's 2017 Elite ...

WILLINGTON, England, June 27, 2024 /PRNewswire/ -- Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare ...

NEW YORK & WILLINGTON, England & FLEMINGTON, N.J.--(BUSINESS WIRE)--Today, Sermo -- a social platform for peer-to-peer physician collaboration and frontline information sharing -- announced a ...

Bionical Emas to further strengthen its position as a market leader in Early Access Programs and Clinical Trial Supply The Company will invest in global expansion and further specialised services to ...

WILLINGTON, England, June 19, 2024 /PRNewswire/ -- Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare ...